Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients.

@article{Matthys1991EffectOS,
  title={Effect of simvastatin treatment on the dyslipoproteinemia in CAPD patients.},
  author={Erv{\'e} Matthys and Mario S Schurgers and Gerard Lamberigts and Norbert R Lameire and N Vandecasteele and Carole Labeur and Ulrike Beisiegel and Maryvonne Rosseneu},
  journal={Atherosclerosis},
  year={1991},
  volume={86 2-3},
  pages={183-92}
}
HMG-CoA reductase inhibitors have been proven effective in decreasing the plasma cholesterol levels in patients affected with various forms of hypercholesterolemia, familial dysbetalipoproteinemia, familial combined hyperlipidemia and in nephrotic and diabetic dyslipidemia. The purpose of this study was to monitor and evaluate the efficiency and safety of… CONTINUE READING